[{"uuid": "47612a9a-7998-3287-a5f5-15ff61271066", "title": "Biogen Stock Down on Regulatory Update in the EU for Alzheimer's Drug", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/biogen-stock-down-regulatory-eu-143100317.html", "providerPublishTime": 1738593060, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/tsWYAfY6SuBuC3962BZpAA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7d0a870e8718511cdf6e5d72d84220a5", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/C3VWzmlS5f5LmkxlbEr6qA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/7d0a870e8718511cdf6e5d72d84220a5", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["BIIB"]}, {"uuid": "be5b8cc1-516c-3a85-b0d5-bf08edee0d53", "title": "Strong week for Castle Biosciences (NASDAQ:CSTL) shareholders doesn't alleviate pain of three-year loss", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/strong-week-castle-biosciences-nasdaq-121723277.html", "providerPublishTime": 1738412243, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/wPCaEqo0Eoh8gNU.SS4ZzA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5bcfe52095f73041f79c669b593d7118", "width": 1194, "height": 432, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/3KT0PYS0wD1QPsJRG80v4w--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5bcfe52095f73041f79c669b593d7118", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CSTL"]}, {"uuid": "4914726d-3902-3b70-823c-e739fe9b7948", "title": "Compass Therapeutics Stock Skyrockets 108% in a Month: Here's Why", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/compass-therapeutics-stock-skyrockets-108-162000718.html", "providerPublishTime": 1738340400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/cYhdSHZ3kDYVQNhcMTsM_w--~B/aD0zOTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4a0e141116a5c1fff5e57140486a1890", "width": 620, "height": 393, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/W5ve9LofNukkX0a38W9plQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/4a0e141116a5c1fff5e57140486a1890", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "2fec5bb4-679f-3136-a6b2-5db18f3d2a8c", "title": "VRTX Gets FDA Nod for Non-Opioid Pain Drug Journavx, Shares Up", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/vrtx-gets-fda-nod-non-155600022.html", "providerPublishTime": 1738338960, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/KEj1lCkxRqndrrMrF3m.HA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c7450ec9df154559fbeb393640d6629", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/L9oXp_PBujUXs0r0RIkKrg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/9c7450ec9df154559fbeb393640d6629", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["VRTX"]}, {"uuid": "fc2b055c-6da9-3c13-9fb7-491bc3c9cf47", "title": "CMRX Stock Skyrockets in 3 Months: Here's What You Should Know", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/cmrx-stock-skyrockets-3-months-154300643.html", "providerPublishTime": 1738338180, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/wYQLwM.yHAc_hHptSu_lhQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/701e76528de32ecfd8ed3df2f647e9a8", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/eA5p1GotBcGPlbcSkQjmLA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/701e76528de32ecfd8ed3df2f647e9a8", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CMRX"]}, {"uuid": "9123b0c6-db7b-3596-aa8b-198a4b9565ad", "title": "Wall Street Analysts Think Castle Biosciences (CSTL) Could Surge 51.52%: Read This Before Placing a Bet", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/wall-street-analysts-think-castle-145505452.html", "providerPublishTime": 1738162505, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/6Ex_CnpNXcMseRWMhPXBow--~B/aD01ODg7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3496571a811465d910e99bd171c71a94", "width": 900, "height": 588, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/FmoTNNnBcLLpLbaF2nY34Q--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/3496571a811465d910e99bd171c71a94", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CSTL"]}, {"uuid": "335d0b5f-cf32-3521-aa0b-e69189d33f91", "title": "FDA Clears Allogene's IND for CAR T Therapy in Autoimmune Diseases", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/fda-clears-allogenes-ind-car-163400440.html", "providerPublishTime": 1738168440, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/_9OKqED6rOANF8VtUei37A--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5d5a6eb884ce28277f39a4369974b5ea", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/QSgbLgHaS28STBWt5rEywQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/5d5a6eb884ce28277f39a4369974b5ea", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ALLO"]}, {"uuid": "efa77b58-362b-3a22-a066-bb27b9dfd6a4", "title": "MRK's sNDA for Welireg in Rare Tumors Gets FDA's Priority Tag", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/mrks-snda-welireg-rare-tumors-171000448.html", "providerPublishTime": 1738084200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/sWuU5JHrorQjYnKhObHttQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1b28b8f55ab25205feceb1a2771a2b3a", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/tX26WfqwElO8vJd.vOvnUg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/1b28b8f55ab25205feceb1a2771a2b3a", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "767e8f8f-b1ad-335f-8b43-1f72fcf1ce6b", "title": "SAGE Rejects Biogen's Offer to Buy Remaining Stake, Stock Up", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/sage-rejects-biogens-offer-buy-165400180.html", "providerPublishTime": 1738083240, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/sb.6qRd7FfGt7.wCjWz2vw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/675c0ae70cb5036ad2ceb9062f13afc2", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/y6B.X5ymHvNNdOly.Nnp7w--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/675c0ae70cb5036ad2ceb9062f13afc2", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["BIIB", "SAGE"]}, {"uuid": "f74ee47e-7f11-3e6e-b09a-0bbf10593535", "title": "FDA Expands Label of AZN's Enhertu for New Breast Cancer Indication", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/fda-expands-label-azns-enhertu-161100900.html", "providerPublishTime": 1738080660, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/6pmiwRZRhtc7hxDNA3zxVQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ef77d5a5eb4e72e4dd31ccfaf4ca4ccd", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/8ePNUSx6ARln9LO4PZCjpQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/ef77d5a5eb4e72e4dd31ccfaf4ca4ccd", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AZN", "4568.T", "CSTL", "BMRN", "ALNY"]}, {"uuid": "2d28728f-cfa0-3d65-9c7c-c9f90f5f24f0", "title": "PFE Stock Rises on Reports of Averting Proxy Fight With Activist Investor", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/pfe-stock-rises-reports-averting-152200714.html", "providerPublishTime": 1738077720, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/IW5EhxEFuSd4V4nUFOhT_A--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1e2f63f10f05b0390ba8b63bd4ef031c", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/AxvgHTECT_FnPZu0GsWG_A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/1e2f63f10f05b0390ba8b63bd4ef031c", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["PFE", "CSTL"]}, {"uuid": "4dd2acb1-4eaf-357e-8cce-38adea2c8005", "title": "MRK Reports Mixed Keytruda Combo Study Data in Gastroesophageal Cancer", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/mrk-reports-mixed-keytruda-combo-154100814.html", "providerPublishTime": 1737992460, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/1YvkxNLsEvDesNn9Nqp_Qw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/df847a6f57145ec8b42be7c65f980057", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/xHdQenrLUaDb1bS06a7i2Q--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/df847a6f57145ec8b42be7c65f980057", "width": 140, "height": 140, "tag": "140x140"}]}}]